Multibagger Selection: GPT-6's picks
GPT-6 picked CRMD, EOSE, AMPX, LUNR, SERV with a twelve-month thesis, measured against SPY at each checkpoint.
| Experiment | Multibagger Selection |
|---|---|
| Model | GPT-6 |
| Prompt version | multibagger-selection-v1 |
| Asked | |
| Horizon | 12-month |
| Benchmark | SPY |
| Status | Being measured |
The picks
| Rank | Symbol | Return | Confidence | vs benchmark | Called right |
|---|---|---|---|---|---|
| 1 | CRMD | — | 84% | — | — |
| 2 | EOSE | — | 77% | — | — |
| 3 | AMPX | — | 80% | — | — |
| 4 | LUNR | — | 81% | — | — |
| 5 | SERV | — | 67% | — | — |
Checkpoints
| Checkpoint | Portfolio return | Return vs SPY | Best peak multiple | Picks reaching 2x |
|---|---|---|---|---|
| 1 week | -2.05% | -1.72% | 1.09x | 0 |
The model's market view
As of October 19, 2026, speculative small-cap equities face substantial financing, execution, and valuation risks. The strongest multibagger opportunities are companies where verifiable commercial progress could produce a fundamental revaluation within 12 months. The five selections emphasize pharmaceutical profitability, energy-storage manufacturing, advanced batteries, space infrastructure, and autonomous robotics. Each has identifiable catalysts, but the quality of evidence and probability of execution differ materially. Threefold appreciation is treated as a conditional economic scenario rather than an expected return. Capitalization and reference prices use available October 19, 2026 intraday quotations. Financial statements generally cover periods through June 30, 2026, except where preliminary third-quarter results have been disclosed. Reverse valuations are illustrative equity-capitalization calculations assuming no material dilution; actual per-share returns could be substantially lower.
Why each pick
CRMD
CorMedix has an unusual combination of commercial profitability, strong historical cash generation, and a modest equity valuation. Q2 2026 consolidated revenue was $101.9 million, comprising $66.1 million from DefenCath and $35.8 million from the acquired Melinta portfolio. Quarterly net income reached $26.0 million and adjusted EBITDA reached $58.7 million. Management maintained FY2026 revenue guidance of $325 million to $345 million and raised adjusted EBITDA guidance to $125 million to $140 million. The central question is whether DefenCath remains meaningfully profitable after temporary reimbursement arrangements expire. The historical earnings multiple is exceptionally low but may reflect a genuine impending earnings reset. On October 19, the FDA announced acceptance of the REZZAYO supplemental application for Priority Review, providing an additional identifiable regulatory catalyst. Current capitalization is approximately $583.80 million based on a $7.49 intraday quote and approximately 77.94 million shares. Sources: https://www.sec.gov/Archives/edgar/data/1410098/000141009826000054/crmd_q22026earningspr.htm and https://stockanalysis.com/stocks/crmd/
EOSE
Eos Energy Enterprises offers substantial operating leverage if its zinc-based long-duration energy-storage manufacturing becomes economically viable at scale. On October 19, management reported preliminary Q3 2026 revenue of $82 million to $83 million, representing approximately 169% to 172% year-over-year growth. Shipments increased approximately 23% sequentially, while contracted backlog reached approximately $765 million. The second production line is expanding output, and manufacturing yields have improved. However, preliminary gross margins remain severely negative at approximately negative 55% to negative 53%. The multibagger thesis therefore requires a major manufacturing cost reduction rather than revenue growth alone. Current capitalization is approximately $682.81 million at a $1.875 intraday reference price. Source: https://www.globenewswire.com/news-release/2026/10/19/3383432/0/en/eos-energy-enterprises-announces-preliminary-third-quarter-2026-revenue-growth-and-continued-gross-margin-improvement-and-sets-conference-call-date.html
AMPX
Amprius Technologies combines rapid revenue growth, improving gross margins, identifiable customer commitments, and expanding advanced battery commercialization. Q2 2026 revenue reached $34 million, increasing 126% year over year. GAAP gross margin improved to 27% from 9% in Q2 2025. Management raised FY2026 revenue guidance to at least $140 million and gross-margin guidance to at least 28%. The company reported a $24 million European drone-battery order and a multiyear Stark Future supply agreement representing an expected revenue opportunity exceeding $100 million. The latter figure is a prospective multiyear opportunity rather than guaranteed 2027 revenue. Valuation already reflects substantial growth expectations. Current capitalization is approximately $1.14 billion at a $7.77 intraday quote. Source: https://ir.amprius.com/news-events/press-releases/detail/172/amprius-technologies-reports-second-quarter-2026-financial-results-and-recent-business-highlights
LUNR
Intuitive Machines is transitioning from a narrowly focused lunar services company toward a diversified space infrastructure and spacecraft contractor. Q2 2026 revenue reached approximately $206 million, more than four times the prior-year quarter. Contracted backlog expanded to approximately $1.8 billion, supported by commercial, civil, and national-security programs. Management guided to $900 million to $1 billion in FY2026 revenue and positive adjusted EBITDA. The scale of contracted activity is substantial relative to historical operations, but the company remains cash-flow negative. Current capitalization is approximately $2.49 billion based on a $10.90 intraday quote. Source: https://www.sec.gov/Archives/edgar/data/1844452/000162828026056476/lunr-20260630xexx991.htm
SERV
Serve Robotics provides speculative multibagger exposure to commercial autonomous delivery and hospital logistics. The company has deployed more than 2,000 robots and acquired Diligent Robotics to expand into hospital applications. Q2 2026 revenue reached approximately $3.24 million, growing 404% year over year. However, commercialization has materially lagged deployment. Management reduced FY2026 revenue guidance to $9 million to $10 million because expected Uber Eats demand failed to materialize. At June 30, 2026, reported net cash was approximately $230.71 million, compared with current equity capitalization near $272.14 million. This apparent cash-backed valuation must be interpreted cautiously because cash burn remains exceptionally high. The 12-month thesis requires a substantial increase in robot utilization and revenue per robot, together with meaningful reductions in cash consumption. The reference price is an October 19 intraday quote. Sources: https://ir.serverobotics.com/news-releases/news-release-details/serve-robotics-announces-second-quarter-2026-results and https://stockanalysis.com/stocks/serv/statistics/
Other models on the same run
| Model | Picks |
|---|---|
| Muse Spark 1.1 | LUNR, PL, RDW, SOUN, BBAI |
| Grok 4.5 | INOD, NRIX, CAPR, PVLA, REPX |
| DeepSeek | ONDS, CRMD, PRE, RZLV, AXTI |
| Gemini 3 Pro | ACHR, SMR, JOBY, RDW, NNE |
ForecastNest provides AI-generated market analysis and quantitative research for informational and educational purposes only. Nothing here constitutes financial, investment, legal, or tax advice.